(PDKs) are promising therapeutic targets that have received increasing attentions in cancer metabolism. In this paper, we report the synthesis and biologicalevaluation of a series of novel dichloroacetophenones as potent PDKs inhibitors. Structure-activityrelationship analysis enabled us to identify a potent compound 6u, which inhibited PDKs with an EC50 value of 0.09 μM, and reduced various cancer
2-(Substituted biphenylyl)propionic acids and salts and esters thereof, said substituents being selected from fluorine and bromine atoms, useful as anti-inflammatory agents, and their preparation.